Pharmacological inhibition of MyD88 was found to protect against renal injury induced by ischemia-reperfusion, both in vivo and in vitro [45], and MyD88 inhibitory peptide was shown to suppress adenovirus type 37-induced keratitis [46]. Here, MYD88 is linked to keratitis.